impact factor, citescore
logo
 

Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983. The journal includes annual monothematic issues on the following topics:

The monothematic issue on Myositis is also the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics, once accepted are published ahead-of-print online, and subsequently included in the correspondent monothematic issue.

Editor-in-Chief
Stefano Bombardieri, MD

Environmental Rheumatology

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €130.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

Education and CME

 

last archive

Quality

The 5 most viewed PDFs in the last 7 days
in press from 6 months ago (One year in review excluded)

From 05/12/2024 to 12/12/2024

CER17988
Free to view
31 click

Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren’s disease: randomised placebo-controlled double-blind clinical study
J. D'agostino Gennari, G.B. Deveza, C.T. Ribeiro, A.C. Seguro, N.E. Aikawa, M.H.M. Shimizu, E.P. Leon, L.K. Guedes, L.V. Kupa, C.A. Silva, E. Bonfa, S.G. Pasoto

Rheumatology Abstract

 

CER17799
Free to view
30 click

A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
D. Khanna, C.P. Denton, S. Assassi, M. Kuwana, Y. Allanore, R.T. Domsic, C. Kleoudis, J. Xu, E. Csomor, C. Seo, M. Albulescu, R. Tummala, H. Al-Mossawi, R.N. Kalyani, F. Del Galdo

Rheumatology Abstract

 

CER17596
Free to view
28 click

Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry
M.S. Chimenti, M. Fatica, M. Fornaro, G. Lopalco, A. Corrado, C. Rotondo, A. Semeraro, S. Colella, E. Praino, R. Gorla, C. Bazzani, G. Babaglioni, R. Foti, A. Floris, B. Frediani, F. Atzeni, F. Conti, A. Cauli, R. Caporali, F. Iannone, S. Guiducci

Rheumatology Abstract

 

CER17475
Free to view
27 click

Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearls
Y.S. Patt, A. Watad, I. Giovannini, W.H. Abu-Obeida, E. Errichetti, P. David, G. De Marco, D. Mcgonagle, A. Zabotti

Rheumatology Abstract

 

CER17790
Free to view
24 click

Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews
E. Carrasco-Vega, S. Guiducci, F. Nacci, S. Bellando Randone, C. Bevilacqua, M. Gonzalez-Sanchez, L. Barni

Rheumatology Abstract

 

The 5 most viewed Abstracts in the last 7 days
in press from 6 months ago (One year in review excluded)

From 05/12/2024 to 12/12/2024

CER17879
123 click

CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related disease
M. Akiyama, K. Yoshimoto, H. Yasuoka, S. Ishigaki, S. Takanashi, T. Takeuchi, Y. Kaneko

Rheumatology Abstract

 

CER17808
Free to view
93 click

A charter to improve care for systemic lupus erythematosus
M. Mosca, J. Andersen, P. Wildman, S. Manzi, Z. Amoura, I. Bultink, O.A. Monticielo, S. Navarra, S. Pettersson

Rheumatology Abstract

 

CER18176
72 click

The clinical characteristics of pharyngeal and laryngeal lesions in anti-MDA5-positive dermatomyositis patients
W. Huang, F. Ren, D. Deng, L. Luo, J. Zhou, D. Huang, M. Tian, D. Chen, K. Qian, Y. Jiang, L. Tang

Rheumatology Abstract

 

CER17913
70 click

Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies
E. Zanatta, B. Moccaldi, A. Martini, L. Ienna, R. Depascale, M. Binda, M. Gatto, M. Zen, M. Tonello, A. Ghirardello, C. Giraudo, E. Balestro, M. Plebani, D. Basso, A. Doria, L. Iaccarino

Rheumatology Abstract

 

CER17688
64 click

Implications of thyroid-related autoantibodies in patients with Sjögren’s syndrome without overt thyroid diseases
Y.-J. Ha, J.-I. Lee, S.R. Choi, E.H. Kang, K.-S. Kim, W.-J. Jeong, J.Y. Hyon, M.J. Kim, S. Cha, Y.J. Lee

Rheumatology Abstract